Company intelligence / Profile preview
CepTor
Denmarkd-ceptor.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
CepTor was a development-stage biopharmaceutical company focused on the discovery and development of proprietary, cell-targeted therapeutics. Its lead program was Myodur for muscular dystrophy. The company had entered into an exclusive license agreement with JCR Pharmaceuticals for Myodur in the Pacific Rim and was set to receive milestone payments upon IND filing. No clinical results or later-stage data are available in public records.
- Therapeutic areas
- Neurology
- Modalities
- Small moleculeProtein
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
03
Partnerships
JCR Pharmaceuticals (exclusive license agreement for Myodur in muscular dystrophy in the Pacific Rim)
Beyond the preview
Go deeper on CepTor.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CepTor.